Skip to main content

Mai-Britt Zocca

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mai-Britt Zocca

Mai-Britt Zocca is recorded as Board Member at IO Biotech, Inc. (IOBTQ). IO Biotech, Inc. reported in an 8-K filed March 31, 2026 that Mai-Britt Zocca was terminated as Chief Executive Officer, effective March 31, 2026. The proxy statement of IO Biotech, Inc. reports total compensation of $1,839,811 for Mai-Britt Zocca in fiscal 2024, including a base salary of $567,788. Disclosed compensation is on record for 5 fiscal years.

“Concurrently with the Petition, on March 31, 2026, the Company terminated all employees and officers without cause, including Mai-Britt Zocca, Chief Executive Officer, and Amy Sullivan, Chief Financial Officer and Chief Accounting Officer.”
IO Biotech, Inc. Form 8-K, filed March 31, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at IO Biotech, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 IO Biotech, Inc. (IOBTQ) $567,788 $1,839,811
2023 IO Biotech, Inc. (IOBTQ) $540,750 $1,645,088
2022 IO Biotech, Inc. (IOBTQ) $515,000 $733,875
2021 IO Biotech, Inc. (IOBTQ) $399,104 $8,153,333
2020 IO Biotech, Inc. (IOBTQ) $307,012 $409,349

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.